feed,title,long_url,short_url
SeekingAlpha,Gamida's rises 5% after cell therapy candidate GDA-501 shows promising antitumor activity against HER2+ cancers,https://seekingalpha.com/news/3902602,
SeekingAlpha,"Palantir slips as Citi sees 'further downside' due to slowing growth, government spending",https://seekingalpha.com/news/3902601,
